RXO stock falls 2.91 percent as quarterly revenue rises 25 percent

Published on 09/23/2026 at 04:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RXO stock closed at USD 19.67 on September 21, 2026, down 2.91 percent from the prior close. Quarterly revenue reached USD 1.77 billion.

RXO, US74981M1099, Illustration mit AI erstellt.

RXO Inc. (ISIN US74981M1099) stock closed at USD 19.67 on the NYSE on September 21, 2026, down USD 0.59, or 2.91 percent, from the prior close. The price stood within a 52-week range of USD 10.43 to USD 29.90, giving the latest session a concrete valuation reference.

Quarterly revenue reaches USD 1.77 billion

According to MarketBeat on September 22, 2026, RXO reported adjusted earnings of USD 0.06 per share for its latest quarter, compared with a consensus estimate of USD 0.04. Revenue reached USD 1.77 billion versus an expected USD 1.63 billion.

The comparison is material: quarterly revenue was USD 140 million above the cited estimate, while year-over-year growth reached 25.0 percent. The same report said adjusted earnings in the comparable quarter had been USD 0.04 per share, putting the latest adjusted figure USD 0.02 higher.

Hold consensus stays above market price

MarketBeat reported on September 22, 2026 that analysts maintained a Hold consensus, comprising four sell ratings, nine hold ratings and six buy ratings. The average 12-month price target was USD 23.91, USD 4.24 above the September 21 closing price.

The market data add a counterweight to the earnings comparison. RXO had a market capitalization of USD 3.24 billion and volume of 1.73 million shares on the cited snapshot, while the 50-day moving average stood at USD 22.46 and the 200-day moving average at USD 21.37.

Stock remains below yearly high

RXO stock closed USD 10.23 below its 52-week high and USD 9.24 above its 52-week low on September 21, 2026. The latest price was therefore closer to the lower end of the annual range than to the high, despite the reported 25.0 percent year-over-year revenue increase.

For investors, the key tension is numerical: the latest quarter exceeded the cited revenue and adjusted earnings estimates, while the share price remained below both reported moving averages and the average analyst target. The figures leave operating execution and future margin development as the main variables for the valuation discussion.